Paroxetine Extended-release Tablets (btn) Manufacturers India, Suppliers
Paroxetine Extended-Release Tablets 12.5mg Manufacturer & Supplier in India
Leading Paroxetine Extended-Release Tablets 12.5mg Manufacturer in India
We are recognized as a trusted and globally established manufacturer, exporter, and supplier of Paroxetine Extended-release Tablets 12.5mg from India. With advanced pharmaceutical manufacturing capabilities and strict adherence to international quality standards, we deliver formulations that meet the expectations of regulated and semi-regulated markets across Africa, the Middle East, and Latin America (LATAM).
Our commitment to innovation, consistency, and compliance has positioned us among the top Paroxetine Extended-release tablet manufacturers in India, offering high-purity formulations designed for optimal therapeutic effectiveness.
What is Paroxetine Extended-Release Tablets 12.5mg?
Paroxetine Extended-release Tablets 12.5mg belong to the class of Selective Serotonin Reuptake Inhibitors (SSRIs). This formulation is specifically designed for controlled release, ensuring a steady level of medication in the bloodstream over time.
It is widely prescribed for the treatment of:
- Major Depressive Disorder (MDD)
- Panic Disorder
- Social Anxiety Disorder (SAD)
- Obsessive-Compulsive Disorder (OCD)
- Generalized Anxiety Disorder (GAD)
By increasing serotonin levels in the brain, it helps improve mood, emotional balance, and mental stability.
Advanced Manufacturing Excellence in India
We operate state-of-the-art manufacturing facilities in Vapi, Gujarat, one of India’s leading pharmaceutical hubs. Our facilities are developed in compliance with:
- WHO-GMP guidelines
- Stringent quality control protocols
- Advanced analytical testing systems
- Scalable production capabilities
Each batch of Paroxetine Extended-release Tablets 12.5mg undergoes rigorous testing to ensure:
- Uniformity of dosage
- Stability and shelf-life
- Bioavailability and efficacy
- Safety and purity
Global Exporter of Paroxetine Extended-Release Tablets
We proudly serve international markets as a reliable exporter of Paroxetine Extended-release Tablets 12.5mg, catering to:
- African pharmaceutical markets
- Middle Eastern healthcare sectors
- LATAM distribution networks
Our export solutions include:
- Regulatory documentation support
- Custom packaging and labeling
- Bulk supply capabilities
- Timely global logistics management
We ensure that our partners receive consistent supply with uncompromised quality standards.
Reliable Supplier & PCD Pharma Franchise Opportunities
We offer flexible business models for distributors and partners seeking:
✔ Bulk Supply & Third-Party Manufacturing
- Large-scale production
- Custom branding options
- Competitive pricing
✔ PCD Pharma Franchise
- Monopoly rights across regions
- Marketing and promotional support
- Assured product availability
- High-margin business model
Our franchise and distribution network spans PAN India, ensuring widespread availability of Paroxetine Extended-release Tablets 12.5mg.
Dosage Guidelines and Administration
We emphasize responsible usage and medical supervision for all pharmaceutical products.
- The dosage is determined by a qualified healthcare professional
- Tablets can be taken with or without food
- Preferably taken at the same time daily
- Morning administration is recommended in case of sleep disturbances
Patients are advised:
- Not to discontinue the medication abruptly
- To follow gradual dose adjustments under medical supervision
- To maintain consistency for optimal results
Therapeutic Benefits of Extended-Release Formulation
The extended-release (CR) mechanism provides multiple clinical advantages:
- Sustained drug release over time
- Reduced dosing frequency
- Lower peak-related side effects
- Improved patient compliance
This makes Paroxetine Extended-release Tablets 12.5mg a preferred choice for long-term management of mental health conditions.
Possible Side Effects and Safety Information
While generally well-tolerated, some patients may experience mild to moderate side effects such as:
- Nausea
- Dry mouth
- Fatigue
- Dizziness
- Insomnia
- Increased sweating
- Constipation
In some cases, patients may also report:
- Reduced libido
- Delayed ejaculation
- Erectile dysfunction
Immediate medical consultation is necessary if:
- There is worsening depression
- Suicidal thoughts occur
- Severe behavioral changes are observed
Why Choose Us as Your Paroxetine Manufacturer in India?
We stand out as a preferred pharmaceutical partner due to:
✔ Quality Assurance
Strict adherence to international manufacturing standards ensures consistent product quality.
✔ Competitive Pricing
Cost-effective solutions without compromising on efficacy and safety.
✔ Global Reach
Strong export network covering multiple international markets.
✔ Regulatory Compliance
Comprehensive documentation and support for global registrations.
✔ Custom Manufacturing
Tailored solutions for private labeling and third-party manufacturing.
Paroxetine Extended-Release Tablets 12.5mg – PAN India Availability
We supply Paroxetine Extended-release Tablets 12.5mg across major Indian cities including:
- Mumbai
- Delhi
- Ahmedabad
- Hyderabad
- Chennai
- Kolkata
Our efficient logistics network ensures timely delivery and consistent stock availability throughout India.
Bulk Orders and Export Inquiries
We welcome global pharmaceutical importers, distributors, and healthcare organizations to partner with us for:
- Bulk procurement
- Long-term supply agreements
- Contract manufacturing
- Exclusive distribution rights
Our team ensures seamless coordination from manufacturing to final delivery.
As a leading manufacturer and exporter of Paroxetine Extended-release Tablets 12.5mg in India, we deliver pharmaceutical excellence backed by innovation, quality, and global trust. Our commitment to improving mental health outcomes drives us to produce formulations that meet the highest international standards.
We continue to expand our global footprint by offering reliable supply, competitive pricing, and unmatched product quality, making us the preferred choice for pharmaceutical partners worldwide.
